/Boston%20Scientific%20Corp_%20logo%20on%20iPad-%20by%20Kate%20Krav-Rude%20via%20Shutterstock.jpg)
Boston Scientific Corporation (BSX), headquartered in Marlborough, Massachusetts, develops, manufactures, and markets medical devices for use in various interventional medical specialties globally. With a market cap of $140.4 billion, the company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, and more. The medTech giant is expected to announce its fiscal fourth-quarter earnings for 2025 before the market opens on Wednesday, Feb. 4.
Ahead of the event, analysts expect BSX to report a profit of $0.78 per share on a diluted basis, up 11.4% from $0.70 per share in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates in its last four quarterly reports.
